These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10867652

  • 21. Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5.
    Choi JS, Kang NS, Min YK, Kim SH.
    Phytother Res; 2010 Jul; 24(7):1042-6. PubMed ID: 19960428
    [Abstract] [Full Text] [Related]

  • 22. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 23. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY.
    Angelini A, Ciofani G, Conti P.
    J Biol Regul Homeost Agents; 2015 May; 29(2):357-65. PubMed ID: 26122223
    [Abstract] [Full Text] [Related]

  • 24. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z, Bens M, Vignes C, Paulais M, Pringel C, Fleury J, Cluzeaud F, Lacave R, Vandewalle A.
    Biochem J; 2003 Feb 15; 370(Pt 1):185-93. PubMed ID: 12435274
    [Abstract] [Full Text] [Related]

  • 25. Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy.
    Angelini A, Conti P, Ciofani G, Cuccurullo F, Di Ilio C.
    J Biol Regul Homeost Agents; 2013 Feb 15; 27(4):1029-37. PubMed ID: 24382184
    [Abstract] [Full Text] [Related]

  • 26. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H, Nguyen-Ba G, Lampidis TJ.
    Pathol Biol (Paris); 1994 Apr 15; 42(4):328-37. PubMed ID: 7808786
    [Abstract] [Full Text] [Related]

  • 27. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I.
    Anticancer Res; 2006 Apr 15; 26(3A):2009-12. PubMed ID: 16827137
    [Abstract] [Full Text] [Related]

  • 28. Essential Oils, Pituranthos chloranthus and Teucrium ramosissimum, Chemosensitize Resistant Human Uterine Sarcoma MES-SA/Dx5 Cells to Doxorubicin by Inducing Apoptosis and Targeting P-Glycoprotein.
    Lahmar A, Mathey A, Aires V, Elgueder D, Vejux A, Khlifi R, Sioud F, Chekir-Ghedira L, Delmas D.
    Nutrients; 2021 May 19; 13(5):. PubMed ID: 34069490
    [Abstract] [Full Text] [Related]

  • 29. 17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
    Gosland M, Tsuboi C, Hoffman T, Goodin S, Vore M.
    Cancer Res; 1993 Nov 15; 53(22):5382-5. PubMed ID: 8106146
    [Abstract] [Full Text] [Related]

  • 30. Clustering of endocytic organelles in parental and drug-resistant myeloid leukaemia cell lines lacking centrosomally organised microtubule arrays.
    Jin J, Pastrello D, Penning NA, Jones AT.
    Int J Biochem Cell Biol; 2008 Nov 15; 40(10):2240-52. PubMed ID: 18439867
    [Abstract] [Full Text] [Related]

  • 31. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH, Kang G, Min YD.
    Planta Med; 2003 Mar 15; 69(3):235-40. PubMed ID: 12677527
    [Abstract] [Full Text] [Related]

  • 32. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov 15; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 33. Lanthionine synthetase components C-like 2 increases cellular sensitivity to adriamycin by decreasing the expression of P-glycoprotein through a transcription-mediated mechanism.
    Park S, James CD.
    Cancer Res; 2003 Feb 01; 63(3):723-7. PubMed ID: 12566319
    [Abstract] [Full Text] [Related]

  • 34. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
    Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, Manfait M, Sockalingum GD.
    Biopolymers; 2006 Aug 05; 82(5):462-70. PubMed ID: 16493658
    [Abstract] [Full Text] [Related]

  • 35. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
    Urasaki Y, Ueda T, Yoshida A, Fukushima T, Takeuchi N, Tsuruo T, Nakamura T.
    Anticancer Res; 1996 Aug 05; 16(2):709-14. PubMed ID: 8687117
    [Abstract] [Full Text] [Related]

  • 36. The potential of a novel polyamine transport inhibitor in cancer chemotherapy.
    Aziz SM, Gillespie MN, Crooks PA, Tofiq SF, Tsuboi CP, Olson JW, Gosland MP.
    J Pharmacol Exp Ther; 1996 Jul 05; 278(1):185-92. PubMed ID: 8764350
    [Abstract] [Full Text] [Related]

  • 37. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 05; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and uptake of fluorescence-labeled Combi-molecules by P-glycoprotein-proficient and -deficient uterine sarcoma cells MES-SA and MES-SA/DX5.
    Larroque-Lombard AL, Todorova M, Golabi N, Williams C, Jean-Claude BJ.
    J Med Chem; 2010 Mar 11; 53(5):2104-13. PubMed ID: 20151639
    [Abstract] [Full Text] [Related]

  • 39. Protein kinase C isoform expression and activity alter paclitaxel resistance in vitro.
    Chen L, Burger RA, Zaunbrecher GM, Cheng H, Lincoln AJ, Mallarino MC, Monk BJ, Khan SA.
    Gynecol Oncol; 1999 Feb 11; 72(2):171-9. PubMed ID: 10021296
    [Abstract] [Full Text] [Related]

  • 40. A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers.
    Tatosian DA, Shuler ML.
    Biotechnol Bioeng; 2009 May 01; 103(1):187-98. PubMed ID: 19137589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.